Entries of Edinger, M. on the publication server

Wolff, D., Greinix, H., Lee, S. J., Gooley, T., Paczesny, S. , Pavletic, S., Hakim, F., Malard, F. , Jagasia, M., Lawitschka, A., Hansen, J. A., Pulanic, D., Holler, E., Dickinson, A., Weissinger, E., Edinger, M., Sarantopoulos, S. and Schultz, K. R. (2018) Biomarkers in chronic graft-versus-host disease: quo vadis? Bone Marrow Transplantation 53 (7), pp. 832-837. Fulltext not available.

Bohmann, E.-M., Fehn, U., Holler, B., Weber, D., Holler, E., Herr, W., Hoffmann, P., Edinger, M. and Wolff, D. (2017) Altered immune reconstitution of B and T cells precedes the onset of clinical symptoms of chronic graft-versus-host disease and is influenced by the type of onset. Annals of Hematology 96 (2), pp. 299-310. Fulltext not available.

Hehlmann, R., Lauseker, M. , Saußele, S., Pfirrmann, M., Krause, S. , Kolb, H. J., Neubauer, A., Hossfeld, D. K., Nerl, C., Gratwohl, A., Baerlocher, G. M., Heim, D., Brümmendorf, T. H., Fabarius, A., Haferlach, C., Schlegelberger, B., Müller, M. C., Jeromin, S., Proetel, U., Kohlbrenner, K., Voskanyan, A., Rinaldetti, S., Seifarth, W., Spieß, B., Balleisen, L., Goebeler, M. C., Hänel, M., Ho, A., Dengler, J., Falge, C., Kanz, L., Kremers, S., Burchert, A., Kneba, M., Stegelmann, F., Köhne, C. A., Lindemann, H. W., Waller, C. F., Pfreundschuh, M., Spiekermann, K., Berdel, W. E., Müller, L., Edinger, M. , Mayer, J., Beelen, D. W., Bentz, M., Link, H., Hertenstein, B., Fuchs, R., Wernli, M., Schlegel, F., Schlag, R., de Wit, M., Trümper, L., Hebart, H., Hahn, M., Thomalla, J., Scheid, C., Schafhausen, P., Verbeek, W., Eckart, M. J., Gassmann, W., Pezzutto, A., Schenk, M., Brossart, P., Geer, T., Bildat, S., Schäfer, E., Hochhaus, A. and Hasford, J. (2017) Assessment of imatinib as first-line treatment of chronic myeloid leukemia: 10-year survival results of the randomized CML study IV and impact of non-CML determinants. Leukemia 31 (11), pp. 2398-2406. Fulltext not available.

Gratwohl, A., Pfirrmann, M., Zander, A., Kröger, N., Beelen, D., Novotny, J., Nerl, C., Scheid, C., Spiekermann, K., Mayer, J., Sayer, H. G., Falge, C., Bunjes, D., Döhner, H., Ganser, A., Schmidt-Wolf, I., Schwerdtfeger, R., Baurmann, H., Kuse, R., Schmitz, N., Wehmeier, A., Fischer, J. Th., Ho, A. D., Wilhelm, M., Goebeler, M.-E., Lindemann, H. W., Bormann, M., Hertenstein, B., Schlimok, G., Baerlocher, G. M., Aul, C., Pfreundschuh, M., Fabian, M., Staib, P., Edinger, M. , Schatz, M., Fauser, A., Arnold, R., Kindler, T., Wulf, G., Rosselet, A., Hellmann, A., Schäfer, E., Prümmer, O., Schenk, M., Hasford, J., Heimpel, H., Hossfeld, D. K., Kolb, H.-J., Büsche, G., Haferlach, C., Schnittger, S., Müller, M. C., Reiter, A., Berger, U., Saußele, S., Hochhaus, A. and Hehlmann, R. (2016) Long-term outcome of patients with newly diagnosed chronic myeloid leukemia: a randomized comparison of stem cell transplantation with drug treatment. Leukemia 30 (3), pp. 562-569. Fulltext not available.

Roll, D., Ammer, J., Holler, B., Salzberger, B., Schweiger, B., Jilg, W., Andreesen, R., Edinger, M. , Wolff, D. and Holler, E. (2012) Vaccination against pandemic H1N1 (2009) in patients after allogeneic hematopoietic stem cell transplantation: a retrospective analysis. Infection 40 (2), pp. 153-161. Fulltext not available.

Boeld, T.J., Spacenko, E., Eder, R., Weber, C., Lang-Schwarz, C., Huber, E., Andreesen, R., Hoffmann, P. and Edinger, M. (2011) Effective Treatment of Acute GvHD After Haploidentical BMT With in vitro Expanded Murine CD4+CD25+ Regulatory T Cells. Biology of Blood and Marrow Transplantation 17 (2), S324. Fulltext not available.

Landfried, K., Bataille, F., Rogler, G. , Brenmoehl, J., Kosovac, K., Wolff, D., Hilgendorf, I. , Hahn, J., Edinger, M. , Hoffmann, P., Obermeier, F., Schoelmerich, J., Andreesen, R. and Holler, Ernst (2009) Recipient NOD2/CARD15 status affects cellular infiltrates in human intestinal graft-versus-host disease. Clinical and Experimental Immunology 159 (1), pp. 87-92. Fulltext not available.